Petty K J, Kokko J P, Marver D
J Clin Invest. 1981 Dec;68(6):1514-21. doi: 10.1172/jci110405.
The possibility that mineralocorticoids have a direct influence on renal Na-K ATPase activity has been the focus of intense research effort and some controversy for a number of years. Early studies were hindered by an inability to differentiate between possible glucocorticoid vs. mineralocorticoid effects on this enzyme within the multitude of cells that comprise the heterogeneous mammalian nephron. This study attempts to circumvent this problem by monitoring Na-K ATPase activity in the rabbit renal cortical collecting tubule (CCT), a proposed target epithelium for mineralocorticoids. Using an ultramicro assay, Na-K ATPase activity was measured in CCT from normal, adrenalectomized (adx), and adx rabbits subjected to one of several corticosteroid treatment protocols. The results indicate that Na-K ATPase activity in the CCT decreased by 86% subsequent to adrenalectomy. Injection of physiological doses of aldosterone (10 micrograms/kg) but not dexamethasone (100 micrograms/kg) restored CCT Na-K ATPase activity in adx rabbits to normal levels within 3 h after injection. An insignificant rise in activity was observed 1.5h after aldosterone treatment. In addition, spirolactone SC 26304, a specific mineralocorticoid antagonist, blocked the action of aldosterone on Na-K ATPase.. Therefore an acute increase in Na-K ATPase activity participates in the action of aldosterone on Na transport in this segment. To differentiate between primary vs. secondary activation of this enzyme, adx animals were treated with amiloride before the injection of aldosterone with the intent of blocking luminal membrane Na entry into CCT. In these animals, pretreatment with amiloride blocked the increase in CCT Na-K ATPase act activity seen with aldosterone alone at 3 h. Thus the increase in activity with aldosterone appears to be a secondary adaptation that is dependent on an aldosterone-enhanced increase in the passive entry of Na across the luminal membrane. The subcellular mechanism by which Na modulates Na-K ATPase activity remains obscure.
多年来,盐皮质激素对肾钠钾ATP酶活性有直接影响这一可能性一直是深入研究的焦点且存在一些争议。早期研究受到阻碍,因为在构成异质性哺乳动物肾单位的众多细胞内,无法区分糖皮质激素和盐皮质激素对该酶可能产生的影响。本研究试图通过监测兔肾皮质集合管(CCT)中的钠钾ATP酶活性来规避这一问题,CCT是盐皮质激素的一个假定靶上皮。使用超微量测定法,在正常、肾上腺切除(adx)以及接受几种皮质类固醇治疗方案之一的adx兔的CCT中测量钠钾ATP酶活性。结果表明,肾上腺切除后CCT中的钠钾ATP酶活性降低了86%。注射生理剂量的醛固酮(10微克/千克)而非地塞米松(100微克/千克)可使adx兔的CCT钠钾ATP酶活性在注射后3小时内恢复到正常水平。醛固酮治疗1.5小时后观察到活性有不显著的升高。此外,特异性盐皮质激素拮抗剂螺内酯SC 26304可阻断醛固酮对钠钾ATP酶的作用。因此,钠钾ATP酶活性的急性增加参与了醛固酮对该节段钠转运的作用。为了区分该酶的原发性激活与继发性激活,在注射醛固酮之前用氨氯吡咪处理adx动物,目的是阻断管腔膜钠进入CCT。在这些动物中,氨氯吡咪预处理可阻断仅用醛固酮时在3小时观察到的CCT钠钾ATP酶活性增加。因此,醛固酮引起的活性增加似乎是一种继发性适应,它依赖于醛固酮增强的钠通过管腔膜的被动进入增加。钠调节钠钾ATP酶活性的亚细胞机制仍不清楚。